Bedside monitoring of antiplatelet therapy for coronary stenting

New England Journal of Medicine

Volumn 368, Issue 9, 2013, Pages 870-872

  Neubauer, Horst ^a   Meves, Saskia H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PURINERGIC RECEPTOR BLOCKING AGENT;

CLINICAL EFFECTIVENESS; CORONARY STENT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; ISCHEMIA; LETTER; MEASUREMENT; MEDICAL DECISION MAKING; MULTIPLE ELECTRODE AGGREGOMETRY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; PLATELET REACTIVITY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOCYTE FUNCTION ANALYZER; CORONARY ARTERY DISEASE; DRUG MONITORING; FEMALE; HOSPITAL INFORMATION SYSTEM; MALE; METHODOLOGY; NOTE; STENT;

CORONARY DISEASE; DRUG MONITORING; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; POINT-OF-CARE SYSTEMS; STENTS;

MLCS; MLOWN;

EID: 84874350530     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1300053     Document Type: Letter

References (5)

1. Collet J-P, Cuisset T, Rangé G, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 2012;367:2100-9.
2. Trenk D, Stone GW, Gawaz M, et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy with Prasugrel) study. J Am Coll Cardiol 2012;59:2159-64.
3. Price MJ, Angiolillo DJ, Teirstein PS, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation 2011;124:1132-7.
4. Aradi D, Komócsi A, Price MJ, et al. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol 2012 June 15 (Epub ahead of print).
5. Siller-Matula JM, Francesconi M, Dechant C, et al. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. Int J Cardiol 2012 May 30 (Epub ahead of print).